In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery

GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to ...
The Manila Times

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means” Segment

The Virtual Investor "What This Means” segment featuring HCW Biologics is now available here.
TipRanks on MSN

NanoViricides says NV-387 shows ‘strong antiviral activity’

NanoViricides (NNVC) announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in cell culture studies as ...
Kauppalehti

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today ...